vs

Side-by-side financial comparison of Kymera Therapeutics, Inc. (KYMR) and Open Lending Corp (LPRO). Click either name above to swap in a different company.

Open Lending Corp is the larger business by last-quarter revenue ($19.3M vs $11.5M, roughly 1.7× Kymera Therapeutics, Inc.). On growth, Open Lending Corp posted the faster year-over-year revenue change (134.0% vs -55.3%). Open Lending Corp produced more free cash flow last quarter ($-3.3M vs $-60.6M). Over the past eight quarters, Kymera Therapeutics, Inc.'s revenue compounded faster (10.1% CAGR vs -20.7%).

Kymera Therapeutics is a clinical-stage biopharmaceutical company specialized in developing innovative targeted protein degradation therapies. It advances a diversified pipeline of drug candidates targeting previously undruggable proteins to address unmet medical needs in oncology, autoimmune and inflammatory diseases worldwide.

Open Library is an online project intended to create "one web page for every book ever published". Created by Aaron Swartz, Brewster Kahle, Alexis Rossi, Anand Chitipothu, and Rebecca Hargrave Malamud, Open Library is a project of the Internet Archive, a nonprofit organization. It has been funded in part by grants from the California State Library and the Kahle/Austin Foundation. Open Library provides online digital copies in multiple formats, created from images of many public domain, out-of...

KYMR vs LPRO — Head-to-Head

Bigger by revenue
LPRO
LPRO
1.7× larger
LPRO
$19.3M
$11.5M
KYMR
Growing faster (revenue YoY)
LPRO
LPRO
+189.2% gap
LPRO
134.0%
-55.3%
KYMR
More free cash flow
LPRO
LPRO
$57.3M more FCF
LPRO
$-3.3M
$-60.6M
KYMR
Faster 2-yr revenue CAGR
KYMR
KYMR
Annualised
KYMR
10.1%
-20.7%
LPRO

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
KYMR
KYMR
LPRO
LPRO
Revenue
$11.5M
$19.3M
Net Profit
$-76.6M
Gross Margin
76.0%
Operating Margin
-736.8%
3.9%
Net Margin
-667.6%
Revenue YoY
-55.3%
134.0%
Net Profit YoY
-82.1%
EPS (diluted)
$-0.95
$-0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KYMR
KYMR
LPRO
LPRO
Q4 25
$19.3M
Q3 25
$24.2M
Q2 25
$11.5M
$25.3M
Q1 25
$22.1M
$24.4M
Q4 24
$7.4M
$-56.9M
Q3 24
$23.5M
Q2 24
$25.6M
$26.7M
Q1 24
$10.3M
$30.7M
Net Profit
KYMR
KYMR
LPRO
LPRO
Q4 25
Q3 25
$-7.6M
Q2 25
$-76.6M
$1.0M
Q1 25
$-65.6M
$617.0K
Q4 24
$-70.8M
Q3 24
$1.4M
Q2 24
$-42.1M
$2.9M
Q1 24
$-48.6M
$5.1M
Gross Margin
KYMR
KYMR
LPRO
LPRO
Q4 25
76.0%
Q3 25
78.0%
Q2 25
78.2%
Q1 25
75.1%
Q4 24
111.0%
Q3 24
73.9%
Q2 24
78.6%
Q1 24
81.3%
Operating Margin
KYMR
KYMR
LPRO
LPRO
Q4 25
3.9%
Q3 25
-31.9%
Q2 25
-736.8%
4.6%
Q1 25
-336.8%
3.1%
Q4 24
-1092.2%
138.0%
Q3 24
7.9%
Q2 24
-198.5%
14.9%
Q1 24
-562.2%
23.8%
Net Margin
KYMR
KYMR
LPRO
LPRO
Q4 25
Q3 25
-31.3%
Q2 25
-667.6%
4.1%
Q1 25
-296.7%
2.5%
Q4 24
-956.9%
Q3 24
6.1%
Q2 24
-164.0%
10.9%
Q1 24
-472.0%
16.5%
EPS (diluted)
KYMR
KYMR
LPRO
LPRO
Q4 25
$-0.00
Q3 25
$-0.06
Q2 25
$-0.95
$0.01
Q1 25
$-0.82
$0.01
Q4 24
$-0.89
$-1.20
Q3 24
$0.01
Q2 24
$-0.58
$0.02
Q1 24
$-0.69
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KYMR
KYMR
LPRO
LPRO
Cash + ST InvestmentsLiquidity on hand
$335.8M
$176.6M
Total DebtLower is stronger
$84.8M
Stockholders' EquityBook value
$971.5M
$75.0M
Total Assets
$1.1B
$236.7M
Debt / EquityLower = less leverage
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KYMR
KYMR
LPRO
LPRO
Q4 25
$176.6M
Q3 25
$222.1M
Q2 25
$335.8M
$230.7M
Q1 25
$90.0M
$236.2M
Q4 24
$120.3M
$243.2M
Q3 24
$250.2M
Q2 24
$67.6M
$248.0M
Q1 24
$93.5M
$247.0M
Total Debt
KYMR
KYMR
LPRO
LPRO
Q4 25
$84.8M
Q3 25
$134.4M
Q2 25
$136.1M
Q1 25
$137.9M
Q4 24
$139.7M
Q3 24
$141.5M
Q2 24
$143.3M
Q1 24
$143.2M
Stockholders' Equity
KYMR
KYMR
LPRO
LPRO
Q4 25
$75.0M
Q3 25
$72.8M
Q2 25
$971.5M
$78.9M
Q1 25
$786.2M
$79.8M
Q4 24
$835.6M
$78.1M
Q3 24
$220.5M
Q2 24
$684.9M
$216.8M
Q1 24
$711.2M
$211.5M
Total Assets
KYMR
KYMR
LPRO
LPRO
Q4 25
$236.7M
Q3 25
$287.7M
Q2 25
$1.1B
$296.7M
Q1 25
$918.3M
$304.2M
Q4 24
$978.0M
$296.4M
Q3 24
$395.7M
Q2 24
$826.0M
$382.8M
Q1 24
$868.3M
$380.6M
Debt / Equity
KYMR
KYMR
LPRO
LPRO
Q4 25
1.13×
Q3 25
1.84×
Q2 25
1.72×
Q1 25
1.73×
Q4 24
1.79×
Q3 24
0.64×
Q2 24
0.66×
Q1 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KYMR
KYMR
LPRO
LPRO
Operating Cash FlowLast quarter
$-59.9M
$-3.2M
Free Cash FlowOCF − Capex
$-60.6M
$-3.3M
FCF MarginFCF / Revenue
-527.9%
-16.8%
Capex IntensityCapex / Revenue
6.1%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-250.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KYMR
KYMR
LPRO
LPRO
Q4 25
$-3.2M
Q3 25
$-5.7M
Q2 25
$-59.9M
$848.0K
Q1 25
$-79.2M
$-3.8M
Q4 24
$-61.8M
$17.6M
Q3 24
$11.4M
Q2 24
$-42.9M
$-1.4M
Q1 24
$-39.6M
$11.0M
Free Cash Flow
KYMR
KYMR
LPRO
LPRO
Q4 25
$-3.3M
Q3 25
Q2 25
$-60.6M
$837.0K
Q1 25
$-79.6M
$-3.9M
Q4 24
$-62.7M
$17.4M
Q3 24
$11.3M
Q2 24
$-47.6M
$-1.5M
Q1 24
$-47.0M
FCF Margin
KYMR
KYMR
LPRO
LPRO
Q4 25
-16.8%
Q3 25
Q2 25
-527.9%
3.3%
Q1 25
-360.3%
-15.9%
Q4 24
-848.3%
-30.6%
Q3 24
48.0%
Q2 24
-185.7%
-5.5%
Q1 24
-456.8%
Capex Intensity
KYMR
KYMR
LPRO
LPRO
Q4 25
0.3%
Q3 25
0.0%
Q2 25
6.1%
0.0%
Q1 25
2.1%
0.2%
Q4 24
12.7%
-0.3%
Q3 24
0.5%
Q2 24
18.3%
0.2%
Q1 24
72.0%
0.0%
Cash Conversion
KYMR
KYMR
LPRO
LPRO
Q4 25
Q3 25
Q2 25
0.82×
Q1 25
-6.22×
Q4 24
Q3 24
7.92×
Q2 24
-0.48×
Q1 24
2.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons